The cost of warfarin treatment for stroke prevention in patients with non-valvular atrial fibrillation in Russia from a collective perspective.

about

The cost of warfarin treatment for stroke prevention in patients with non-valvular atrial fibrillation in Russia from a collective perspective.

Item

http://www.wikidata.org/entity/Q38984688

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

The cost of warfarin treatment ...... from a collective perspective.

@en

type

Item

label

The cost of warfarin treatment ...... from a collective perspective.

@en

prefLabel

The cost of warfarin treatment ...... from a collective perspective.

@en

P1476

The cost of warfarin treatment ...... from a collective perspective.

@en

P2093

B Tatarsky

http://www.w3.org/2001/XMLSchema#string

J B Briere

http://www.w3.org/2001/XMLSchema#string

J Roberts

http://www.w3.org/2001/XMLSchema#string

K Bowrin

http://www.w3.org/2001/XMLSchema#string

R Wood

http://www.w3.org/2001/XMLSchema#string

P2860

Review of epidemiology and management of atrial fibrillation in developing countries

Atrial fibrillation as an independent risk factor for stroke: the Framingham Study

2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association

Resource consumption and management associated with monitoring of warfarin treatment in primary health care in Sweden.

A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey.

Systematic overview of warfarin and its drug and food interactions.

Quality of life in patients with atrial fibrillation: a systematic review.

Impact of global geographic region on time in therapeutic range on warfarin anticoagulant therapy: data from the ROCKET AF clinical trial.

Risk profiles and antithrombotic treatment of patients newly diagnosed with atrial fibrillation at risk of stroke: perspectives from the international, observational, prospective GARFIELD registry.

Anticoagulants for atrial fibrillation: why is the treatment rate so low?

P304

599-605

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/13696998.2017.1290641

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-02-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28151036

http://www.w3.org/2001/XMLSchema#string